# Avicena LVDP Validation Study

Study · id `cardio:ct-nct05633004` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05633004](<https://clinicaltrials.gov/study/NCT05633004>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05633004

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 406 participants.

## Technical summary

Registry record NCT05633004. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-27 (actual); primary completion 2022-09-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 406 participants (enrolled count; ClinicalTrials.gov record NCT05633004, source copy `cardio:ctgov-nct05633004-2022-12-01`, retrieved 2026-10-26)
- Started: 2021-09-27 (actual) (ClinicalTrials.gov record NCT05633004, source copy `cardio:ctgov-nct05633004-2022-12-01`, retrieved 2026-10-26)
- Primary completion: 2022-09-08 (actual) (ClinicalTrials.gov record NCT05633004, source copy `cardio:ctgov-nct05633004-2022-12-01`, retrieved 2026-10-26)
- Completion: 2022-09-30 (actual) (ClinicalTrials.gov record NCT05633004, source copy `cardio:ctgov-nct05633004-2022-12-01`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05633004, source copy `cardio:ctgov-nct05633004-2022-12-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05633004-2022-12-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Avicena LVDP Validation Study
- Condition: Heart Failure
- Intervention (Device): Vivio
- Lead sponsor: Ventric Health, LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 1dea17d55a8332ab45da83a09d2ca75361ae0ef6591608d109059861239639c3
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
